Where things stand

March 16, 2021
USDA is seeking input on “climate-smart agriculture and forestry strategy”—and BIO’s on it. We also have positive headlines from BIO members working on COVID-19 vaccines and therapeutics as well as news from the Capitol. (859 words, 4 minutes, 17 seconds) P.S. BIO…
BIO

USDA is seeking input on “climate-smart agriculture and forestry strategy”—and BIO’s on it. We also have positive headlines from BIO members working on COVID-19 vaccines and therapeutics as well as news from the Capitol. (859 words, 4 minutes, 17 seconds)

P.S. BIO Digital registration opens today! There are big savings if you register by April 11. Get the details.

 

Where things stand

 
 

The numbers are looking better—but there’s still a lot of work to do to end the pandemic. Here’s where things stand, including promising news from a few BIO members.

More than 109 million COVID-19 vaccine doses have been administered in the United States, with 11.5% of Americans now fully vaccinated, according to Bloomberg

But the virus isn’t going away and there’s still a lot of work to do—especially when it comes to battling new variants, ensuring vaccines are distributed equitably, and developing effective therapeutics

Luckily, the biotechnology industry is continuing its unprecedented fight to defeat the virus—and we saw several positive developments over the last week.

Moderna launched a phase 1 trial of a “next-generation” COVID-19 vaccine, “a potential refrigerator-stable vaccine that could facilitate easier distribution and administration in a wider range of settings,” Moderna CEO Stéphane Bancel said yesterday.

Moderna also dosed participants in a trial evaluating booster vaccines against the variant first identified in South Africa. The 60 participants were previously vaccinated with Moderna’s authorized vaccine and will receive one of three booster candidates

And as we noted last week, Novavax said its vaccine candidate is effective against the original strain and variants identified in the UK and South Africa,providing 100% protection against severe disease.

Watch:Novavax CEO Stanley Erck joined Yahoo! Finance to discuss when the company expects their vaccine could be authorized

We’re also seeing progress on therapeutics—including Vir and GSK announcing last week that their monoclonal antibody reduces hospitalization and death by 85%.

What else is in the COVID-19 pipeline? Check out BIO’s COVID-19 Therapeutic Development Tracker to see the latest progress in the industry.  

Speaking of vaccine equity, as we're sending this, BIO's Dr. Michelle McMurry-Heath is on a virtual "media tour" across the United States, hitting local television and radio stations in about 19 markets to talk about why everyone should get the COVID-19 vaccine. If you spot her on your TV this morning, tweet us a screengrab or clip!

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 

USDA seeks input on climate

 
 

The U.S. Department of Agriculture (USDA) is requesting input on a “climate-smart agriculture and forestry strategy”—and BIO’s on it.

USDA is soliciting stakeholder input on four topics: climate-smart agriculture and forestry; biofuels, bioproducts, and renewable energy; catastrophic wildfire; and meeting the needs of disadvantaged communities. 

“We want your ideas on how to position the agriculture and forestry sectors to be leaders on climate smart practices to mitigate climate change,”said Agriculture Secretary Tom Vilsack. “This includes making the most of USDA programs, developing new USDA-led climate strategies, strengthening existing markets, and developing new markets that generate income.” 

This is a step towards implementing President Biden’s executive order on climate, which focused on optimizing federal programs to reduce carbon and create new sources of income and jobs for rural Americans, among other goals.

“To meet climate change commitments, it is crucial to lead with science and U.S. innovation,” BIO has said. “We must incentivize the adoption of innovative and sustainable technologies and practices and streamline and expedite regulatory pathways for breakthrough technology solutions.”  

BIO has long championed the advancement of biotechnologies to respond to the climate crisis. In fact, this year alone:

The next steps: USDA is accepting public comments until April 30. As the administration continues to take action on climate in the coming months, BIO will continue to lead in explaining the critical role of biotechnology and innovation. 

Learn more about how biotech can help us meet our climate policy goals.

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 
BIO's Phyllis Arthur - Women's History Month

Here’s a piece of advice: pursue your passion for science.

Phyllis Arthur, BIO’s VP of Infectious Diseases and Diagnostics Policy, says that’s what she would tell her younger self—and it’s good advice for all young women who find they have an interest in STEM. 

Arthur earned her bachelor’s degree in economics and international politics from Goucher College and MBA from the Wharton School of Business at the University of Pennsylvania—but she was always good at science and enjoyed it.

“I would look back and tell myself, you’re going to really enjoy this—it’s one of your passions. You should continue to study it,” she said.

Even without the science degree, Arthur has put her talents to use for patients—and made important contributions to the biotech industry. Over the past year, she has been BIO’s leading voice in the fight against COVID-19. Her long career has included leading marketing and sales teams at Merck where she launched several exciting new vaccines including the first HPV vaccine, GARDASIL.

She joined BIO in 2009; in her current role, she works with member companies in vaccines, molecular diagnostics, and bio-defense on policy, legislative, and regulatory issues.

 
BIO Beltway Report
BIO Beltway Report
 
Paragraph (sm) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel facilisis sample link.
 

President Biden’s Tuesday: Heading to Chester, PA, to visit a small business. Meanwhile, the White House is launching a campaign to combat vaccine hesitancy, STAT News reports

What’s Happening on Capitol Hill: The Senate confirmed Deb Haaland as Interior secretary, the first Native American Cabinet secretary. The vote on Katherine Tai, Biden’s nominee for U.S. Trade Representative, could happen as early as today. In the meantime, we’re watching the Senate Finance Committee hearing, Made in America: Effect of the U.S. Tax Code on Domestic Manufacturing.

 
 
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
Twitter
 
LinkedIn
 
Facebook